. 2016 Aug 12;5(9):2378–2384. doi: 10.1002/cam4.835

Table 1.

Baseline clinical and biological characteristics of the patients studied and summary of the hybrid imaging patterns observed with the two radiopharmaceuticals used

	Axial skeleton		Spleen		Liver		Distal skeleton		EMH SPECT/CT		Disease status and molecular profile
	^99mTc	¹¹¹In	^99mTc	¹¹¹In	^99mTc	¹¹¹In	^99mTc	¹¹¹In	^99mTc	¹¹¹In	Disease status and molecular profile
P1	Fixation	Lower fixation	Hyperfixation	Hyperfixation	Hyperfixation	Fixation	Fixation	Higher fixation	Neg	Neg	PMF‐F V617F‐JAK2^pos
P2	Fixation	Fixation	Fixation	Hyperfixation	Fixation	Fixation	Fixation	Higher fixation	Neg	Neg	PMF‐F JAK2^pos (exon12) CALR^neg MPL^neg
P3	Lower fixation	Lower fixation	Fixation	Hyperfixation	Fixation	Fixation	Fixation	Higher fixation	Neg	Neg	PMF‐F JAK2^pos (exon12) CALR^neg MPL^neg
P4	Lower fixation	Fixation	Fixation	Hyperfixation	Fixation	Fixation	Fixation	Higher fixation	Neg	Neg	PMF‐F V671F‐ JAK2^pos
P5	Lower fixation	Fixation	Fixation	Fixation	Fixation	Fixation	No fixation	No fixation	Neg	Neg	Post‐TE‐MF V617F‐JAK2^pos
P6	Very low fixation	Fixation	Fixation	Hyperfixation	Fixation	Fixation	Low fixation	Higher fixation	Neg	Neg	PMF‐F V617F‐JAK2^pos

SPECT/CT, single‐photon emission tomography/computed tomography; EMH, extramedullary hematopoiesis; PMF, primary myelofibrosis.